Open Access

Rhizopus oryzae AM16; a new hyperactive L‑asparaginase producer: Semi solid‑state production and anticancer activity of the partially purified protein

  • Authors:
    • Sarah I. Othman
    • Amal A.I. Mekawey
    • Mohammad M. El‑Metwally
    • Sami A. Gabr
    • Maha Abdulla Alwaele
    • Haifa Al Fassam
    • Rasha Abo‑Eleneen
    • Ahmed A. Allam
    • Wesameldin I.A. Saber
  • View Affiliations

  • Published online on: January 14, 2022     https://doi.org/10.3892/br.2022.1498
  • Article Number: 15
  • Copyright: © Othman et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The demand for L‑asparaginase is predicted to increase several fold in the future due to its potential clinical applications in the treatment of lymphoid system malignancies and leukemia. Thus identifying suitable sources of production should be considered high priority. Fungi are valuable organisms as they are able to convert what would be considered ‘useless’ materials into materials that have potential value. The present study provides a proof of concept of production of a new hyperactive L‑asparaginase producer (Rhizopus oryzae AM16), which was successfully isolated and sequentially optimized using a semi solid‑state fermentation method with a simple and cheap medium produced from wheat bran (WB). The fungus was able to produce an appreciable amount of the enzyme (2,875.9 U) after 8 days of incubation under 85.7% moisture, in the presence of magnesium nitrate (5.0 mg N/mg nitrogen per gram of dry WB) at pH 5.8. Testing the anticancer activity confirmed the ability of the resultant enzyme to inhibit the growth of various types of cancer cells (HepG2, MCF‑7, HCT and A549). The IC50 values of the dialyzed enzyme were lower than that of the crude product. Thus, this newly identified and purified L‑asparaginase may be a promising anticancer drug.
View Figures
View References

Related Articles

Journal Cover

March-2022
Volume 16 Issue 3

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Othman SI, Mekawey AA, El‑Metwally MM, Gabr SA, Alwaele MA, Al Fassam H, Abo‑Eleneen R, Allam AA and Saber WI: <em>Rhizopus oryzae</em> AM16; a new hyperactive L‑asparaginase producer: Semi solid‑state production and anticancer activity of the partially purified protein. Biomed Rep 16: 15, 2022
APA
Othman, S.I., Mekawey, A.A., El‑Metwally, M.M., Gabr, S.A., Alwaele, M.A., Al Fassam, H. ... Saber, W.I. (2022). <em>Rhizopus oryzae</em> AM16; a new hyperactive L‑asparaginase producer: Semi solid‑state production and anticancer activity of the partially purified protein. Biomedical Reports, 16, 15. https://doi.org/10.3892/br.2022.1498
MLA
Othman, S. I., Mekawey, A. A., El‑Metwally, M. M., Gabr, S. A., Alwaele, M. A., Al Fassam, H., Abo‑Eleneen, R., Allam, A. A., Saber, W. I."<em>Rhizopus oryzae</em> AM16; a new hyperactive L‑asparaginase producer: Semi solid‑state production and anticancer activity of the partially purified protein". Biomedical Reports 16.3 (2022): 15.
Chicago
Othman, S. I., Mekawey, A. A., El‑Metwally, M. M., Gabr, S. A., Alwaele, M. A., Al Fassam, H., Abo‑Eleneen, R., Allam, A. A., Saber, W. I."<em>Rhizopus oryzae</em> AM16; a new hyperactive L‑asparaginase producer: Semi solid‑state production and anticancer activity of the partially purified protein". Biomedical Reports 16, no. 3 (2022): 15. https://doi.org/10.3892/br.2022.1498